NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 70 filers reported holding NEOS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $189,000 | -22.2% | 38,908 | 0.0% | 0.01% | -26.7% |
| Q2 2018 | $243,000 | -39.7% | 38,908 | -19.8% | 0.02% | -48.3% |
| Q1 2018 | $403,000 | -13.5% | 48,532 | +6.1% | 0.03% | -21.6% |
| Q4 2017 | $466,000 | -45.0% | 45,721 | -50.6% | 0.04% | -51.3% |
| Q3 2017 | $847,000 | +81.0% | 92,567 | +44.3% | 0.08% | +72.7% |
| Q2 2017 | $468,000 | +108.9% | 64,157 | +105.9% | 0.04% | +109.5% |
| Q1 2017 | $224,000 | +163.5% | 31,157 | +113.6% | 0.02% | +110.0% |
| Q4 2016 | $85,000 | – | 14,587 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 693,582 | $4,057,000 | 2.30% |
| DAFNA Capital Management LLC | 38,873 | $227,000 | 0.20% |
| FALCON POINT CAPITAL, LLC | 85,588 | $501,000 | 0.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,341,000 | 0.06% |
| Cormorant Asset Management, LP | 50,613 | $296,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 14,587 | $85,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $468,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 296,175 | $1,733,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,315,500 | $7,696,000 | 0.00% |
| COLUMBUS CIRCLE INVESTORS | 42,304 | $247,000 | 0.00% |